Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtre
1.
Mem. Inst. Oswaldo Cruz ; 109(2): 154-162, abr. 2014. tab, graf
Article Dans Anglais | LILACS | ID: lil-705821

Résumé

Haematological and cytokine alterations in malaria are a broad and controversial subject in the literature. However, few studies have simultaneously evaluated various cytokines in a single patient group during the acute and convalescent phases of infection. The aim of this study was to sequentially characterise alterations in haematological patters and circulating plasma cytokine and chemokine levels in patients infected with Plasmodium vivax or Plasmodium falciparum from a Brazilian endemic area during the acute and convalescent phases of infection. During the acute phase, thrombocytopaenia, eosinopaenia, lymphopaenia and an increased number of band cells were observed in the majority of the patients. During the convalescent phase, the haematologic parameters returned to normal. During the acute phase, P. vivax and P. falciparum patients had significantly higher interleukin (IL)-6, IL-8, IL-17, interferon-γ, tumour necrosis factor (TNF)-α, macrophage inflammatory protein-1β and granulocyte-colony stimulating factor levels than controls and maintained high levels during the convalescent phase. IL-10 was detected at high concentrations during the acute phase, but returned to normal levels during the convalescent phase. Plasma IL-10 concentration was positively correlated with parasitaemia in P. vivax and P. falciparum-infected patients. The same was true for the TNF-α concentration in P. falciparum-infected patients. Finally, the haematological and cytokine profiles were similar between uncomplicated P. falciparum and P. vivax infections.


Sujets)
Adulte , Femelle , Humains , Mâle , Convalescence , Cytokines/sang , Paludisme à Plasmodium falciparum/sang , Paludisme à Plasmodium vivax/sang , Maladie aigüe , Brésil , Études cas-témoins , /sang , Chimiokines/sang , Facteur de stimulation des colonies de granulocytes/sang , Hématocrite , Inflammation , Interféron gamma/sang , Interleukine-1 bêta/sang , /sang , /sang , /sang , /sang , /sang , /sang , Paludisme à Plasmodium falciparum/immunologie , Paludisme à Plasmodium vivax/immunologie , Parasitémie , Plasmodium falciparum/isolement et purification , Plasmodium vivax/isolement et purification , Statistique non paramétrique , Facteur de nécrose tumorale alpha/sang
2.
Mem. Inst. Oswaldo Cruz ; 108(4): 523-528, jun. 2013. tab, graf
Article Dans Anglais | LILACS | ID: lil-678293

Résumé

The genetic diversity displayed by Plasmodium falciparum, the most deadly Plasmodium species, is a significant obstacle for effective malaria vaccine development. In this study, we identified genetic polymorphisms in P. falciparum glutamate-rich protein (GLURP), which is currently being tested in clinical trials as a malaria vaccine candidate, from isolates found circulating in the Brazilian Amazon at variable transmission levels. The study was performed using samples collected in 1993 and 2008 from rural villages situated near Porto Velho, in the state of Rondônia. DNA was extracted from 126 P. falciparum-positive thick blood smears using the phenol-chloroform method and subjected to a nested polymerase chain reaction protocol with specific primers against two immunodominant regions of GLURP, R0 and R2. Only one R0 fragment and four variants of the R2 fragment were detected. No differences were observed between the two time points with regard to the frequencies of the fragment variants. Mixed infections were uncommon. Our results demonstrate conservation of GLURP-R0 and limited polymorphic variation of GLURP-R2 in P. falciparum isolates from individuals living in Porto Velho. This is an important finding, as genetic polymorphisms in B and T-cell epitopes could have implications for the immunological properties of the antigen.


Sujets)
Humains , Acide glutamique/génétique , Paludisme à Plasmodium falciparum/parasitologie , Plasmodium falciparum/génétique , Polymorphisme génétique/génétique , Protéines de protozoaire/génétique , Brésil/épidémiologie , Génotype , Paludisme à Plasmodium falciparum/épidémiologie , Réaction de polymérisation en chaîne
3.
Mem. Inst. Oswaldo Cruz ; 107(8): 1035-1041, Dec. 2012. graf
Article Dans Anglais | LILACS | ID: lil-660652

Résumé

The haematological changes and release of soluble mediators, particularly C-reactive protein (CRP) and nitric oxide (NO), during uncomplicated malaria have not been well studied, especially in Brazilian areas in which the disease is endemic. Therefore, the present study examined these factors in acute (day 0) and convalescent phase (day 15) patients infected with Plasmodium falciparum and Plasmodium vivax malaria in the Brazilian Amazon. Haematologic parameters were measured using automated cell counting, CRP levels were measured with ELISA and NO plasma levels were measured by the Griess reaction. Our data indicate that individuals with uncomplicated P. vivax and P. falciparum infection presented similar inflammatory profiles with respect to white blood cells, with high band cell production and a considerable degree of thrombocytopaenia during the acute phase of infection. Higher CRP levels were detected in acute P. vivax infection than in acute P. falciparum infection, while higher NO was detected in patients with acute and convalescent P. falciparum infections. Although changes in these mediators cannot predict malaria infection, the haematological aspects associated with malaria infection, especially the roles of platelets and band cells, need to be investigated further.


Sujets)
Adulte , Femelle , Humains , Mâle , Plaquettes/immunologie , Protéine C-réactive/analyse , Médiateurs de l'inflammation/sang , Paludisme à Plasmodium falciparum/sang , Paludisme à Plasmodium vivax/sang , Granulocytes neutrophiles/immunologie , Monoxyde d'azote/sang , Maladie aigüe , Convalescence , Test ELISA , Paludisme à Plasmodium falciparum/diagnostic , Paludisme à Plasmodium falciparum/immunologie , Paludisme à Plasmodium vivax/diagnostic , Paludisme à Plasmodium vivax/immunologie
4.
Mem. Inst. Oswaldo Cruz ; 106(supl.1): 34-43, Aug. 2011. ilus, graf, tab
Article Dans Anglais | LILACS | ID: lil-597242

Résumé

The glutamate-rich protein (GLURP) is an exoantigen expressed in all stages of the Plasmodium falciparum life cycle in humans. Anti-GLURP antibodies can inhibit parasite growth in the presence of monocytes via antibody-dependent cellular inhibition (ADCI), and a major parasite-inhibitory region has been found in the N-terminal R0 region of the protein. Herein, we describe the antiplasmodial activity of anti-GLURP antibodies present in the sera from individuals naturally exposed to malaria in a Brazilian malaria-endemic area. The anti-R0 antibodies showed a potent inhibitory effect on the growth of P. falciparum in vitro, both in the presence (ADCI) and absence (GI) of monocytes. The inhibitory effect on parasite growth was comparable to the effect of IgGs purified from pooled sera from hyperimmune African individuals. Interestingly, in the ADCI test, higher levels of tumour necrosis factor alpha (TNF-α) were observed in the supernatant from cultures with higher parasitemias. Our data suggest that the antibody response induced by GLURP-R0 in naturally exposed individuals may have an important role in controlling parasitemia because these antibodies are able to inhibit the in vitro growth of P. falciparum with or without the cooperation from monocytes. Our results also indicate that TNF-α may not be relevant for the inhibitory effect on P. falciparum in vitro growth.


Sujets)
Adolescent , Adulte , Sujet âgé , Humains , Adulte d'âge moyen , Jeune adulte , Anticorps antiprotozoaires/immunologie , Paludisme à Plasmodium falciparum , Plasmodium falciparum/croissance et développement , Protéines de protozoaire/immunologie , Maladies endémiques , Test ELISA , Technique d'immunofluorescence indirecte , Immunoglobuline G/immunologie , Paludisme à Plasmodium falciparum/sang , Paludisme à Plasmodium falciparum/immunologie , Parasitémie , Plasmodium falciparum/immunologie , Protéines de protozoaire , Facteur de nécrose tumorale alpha/sang
SÉLECTION CITATIONS
Détails de la recherche